The initiative continues to support innovative seed and early-stage companies by helping them bring their ideas to life with end-to-end MVP, web, and mobile app development needs.
DASA is inviting innovators to apply for its latest opportunities, including a market exploration on conflict wound management and an upcoming competition on tackling non-compressible haemorrhage. Ideas with potential for both defence and civilian healthcare are welcome.
The £7.5 million Longitude Prize on ALS is an international challenge prize to incentivize the use of AI-based approaches to transform drug discovery for the treatment of amyotrophic lateral sclerosis (ALS), the most common form of motor neurone disease (MND).
